Filing Details
- Accession Number:
- 0001651844-19-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-07 11:42:21
- Reporting Period:
- 2019-06-06
- Accepted Time:
- 2019-06-07 11:42:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-06 | 1,000 | $1.52 | 3,374,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 400 | $1.53 | 3,374,950 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 1,100 | $1.53 | 3,376,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 799 | $1.54 | 3,376,849 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 800 | $1.55 | 3,377,649 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 600 | $1.56 | 3,378,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 100 | $1.58 | 3,378,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-06 | 5,201 | $1.59 | 3,383,550 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
